| NCT ID | NCT06382480 |
| Status | Recruiting |
| Phase | — |
| Sponsor | German Institute of Human Nutrition |
| Condition | Overweight |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-04-12 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-04-12 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall aim is to identify the dietary pattern for prevention and treatment of type 2 diabetes. The specific aim of this pilot project is to compare effects of two diets with different diurnal distribution of carbohydrates and protein on the glucose metabolism in subjects with prediabetes and type 2 diabetes and its effects on inflammatory status.
Eligibility Criteria
Inclusion Criteria: * Prediabetes (fasting blood sugar 100-125 mg/dl) * Diabetes type 2 (fasting blood sugar \>126 mg/dl) * Overweight and obesity (BMI 25-50 kg/m2) Exclusion Criteria: * Other diabetes types * Insulin treatment * Shift work * Weight changes \>5% within past 3 months * Systemic glucocorticoid therapy * Systemic infections * Severe anemia * High blood pressure (\>180/110 mmHg) * Endocrinologic, liver and heart disorders * Immune diseases * Thyroid dysfunction * Heart attack or stroke * Cancer in the last 2 years * Eating disorders, food intolerance/allergy, addiction disorders, digestive disorders intestinal, liver, cardiovascular diseases * Hereditary or acquired coagulation disorders * Non-interruptible intake of blood thinners (anticoagulants) * Specific diets, intermittent fasting * Pregnancy or breastfeeding * Severe internal or psychiatric disorders or other conditions and drugs therapy that might influence the outcome of the study
Contact & Investigator
Olga Ramich, PD Dr.
PRINCIPAL INVESTIGATOR
German Institute of Human Nutrition
Frequently Asked Questions
Who can join the NCT06382480 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06382480 currently recruiting?
Yes, NCT06382480 is actively recruiting participants. Contact the research team at olga.ramich@dife.de for enrollment information.
Where is the NCT06382480 trial being conducted?
This trial is being conducted at Potsdam, Germany.
Who is sponsoring the NCT06382480 clinical trial?
NCT06382480 is sponsored by German Institute of Human Nutrition. The principal investigator is Olga Ramich, PD Dr. at German Institute of Human Nutrition. The trial plans to enroll 30 participants.